Daxor corporation awarded $305k grant from the national institutes of health to develop blood volume guidance software in sepsis patients

Oak ridge, tn, sept. 11, 2023 (globe newswire) -- daxor c orporation (nasdaq: dxr), the global leader in blood volume measurement technology, today announced that the national institutes of health (nih) national institute of general medical sciences (nigms) has awarded the company a $305k phase i small business innovative research (sbir) grant to support the development of the sepsis flo (sepsis fluid optimizer), a clinical decision support tool designed to precisely guide blood volume management and treatment in sepsis patients.
DXR Ratings Summary
DXR Quant Ranking